153 related articles for article (PubMed ID: 2112051)
1. Comparative studies on the action of 7-N-[2-[[2-(gamma-L-glutamylamino)ethyl]dithio]ethyl]mitomycin C and of mitomycin C on cultured HL-60 cells and isolated phage and plasmid DNA.
Ishioka C; Kanamaru R; Konishi Y; Ishikawa A; Shibata H; Wakui A
Cancer Chemother Pharmacol; 1990; 26(2):117-21. PubMed ID: 2112051
[TBL] [Abstract][Full Text] [Related]
2. Phage inactivation and DNA strand scission activities of 7-N-(p-hydroxyphenyl)mitomycin C.
Ueda K; Morita J; Komano T
J Antibiot (Tokyo); 1982 Oct; 35(10):1380-6. PubMed ID: 6217180
[TBL] [Abstract][Full Text] [Related]
3. Nonenzymatic reductive activation of 7-N-((2-([2-(gamma-L-glutamylamino)ethyl]dithio)ethyl))mitomycin C by thiol molecules: a novel mitomycin C derivative effective on mitomycin C-resistant tumor cells.
Lee JH; Naito M; Tsuruo T
Cancer Res; 1994 May; 54(9):2398-403. PubMed ID: 8162587
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of 7-N-[[2-[[2-(gamma-L-glutamylamino)ethyl]dithio]ethyl]]-mitomycin C.
Morimoto M; Ashizawa T; Ohno H; Azuma M; Kobayashi E; Okabe M; Gomi K; Kono M; Saitoh Y; Kanda Y
Cancer Res; 1991 Jan; 51(1):110-5. PubMed ID: 1988076
[TBL] [Abstract][Full Text] [Related]
5. Circumvention of glutathione-mediated mitomycin C resistance by a novel mitomycin C analogue, KW-2149.
Ishida T; Nishio K; Kurokawa H; Arioka H; Fukumoto H; Fukuoka K; Nomoto T; Yokote H; Hasegawa S; Saijo N
Int J Cancer; 1997 Sep; 72(5):865-70. PubMed ID: 9311606
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of action of the synthetic imidazole compound YM 534 on human promyelocytic leukemia line HL-60 cells.
Kanamaru R; Ishioka C; Konishi Y; Ishikawa A; Shibata H; Wakui A
Anticancer Drug Des; 1989 Aug; 4(2):137-44. PubMed ID: 2803462
[TBL] [Abstract][Full Text] [Related]
7. 7-N-(2-([2-(gamma-L-glutamylamino)-ethyl]-dithio)-ethyl)-mitomycin C (KW-2149) is more active than mitomycin C on chemonaive and drug-resistant urothelial carcinoma cells.
Rohde D; Raffenberg G; Kaviani S; Wolff J; Jakse G
Urol Res; 1998; 26(4):243-7. PubMed ID: 9759997
[TBL] [Abstract][Full Text] [Related]
8. DNA damage, cytotoxicity and free radical formation by mitomycin C in human cells.
Dusre L; Covey JM; Collins C; Sinha BK
Chem Biol Interact; 1989; 71(1):63-78. PubMed ID: 2550152
[TBL] [Abstract][Full Text] [Related]
9. DNA breaks and repair in the mouse leukemia L1210 cells exposed to three different types of interstrand DNA cross-linkers.
Yajima N; Hochi S; Miyata N; Kishi T; Kawanishi G
Mutat Res; 1990 Jul; 236(1):43-50. PubMed ID: 2114540
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of a derivative of mitomycin, 7-N-[2-[[2-(gamma-L-glutamylamino)ethyl]dithio]ethyl]mitomycin C (KW-2149), against murine and human tumors and a mitomycin C-resistant tumor in vitro and in vivo.
Tsuruo T; Sudo Y; Asami N; Inaba M; Morimoto M
Cancer Chemother Pharmacol; 1990; 27(2):89-93. PubMed ID: 2123421
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamics of mitomycin C in cultured human bladder tumors.
Schmittgen TD; Wientjes MG; Badalament RA; Au JL
Cancer Res; 1991 Aug; 51(15):3849-56. PubMed ID: 1906778
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic activity of 7-N-(2-((2-(-gamma-L-glutamylamino)- ethyl)dithio)ethyl)-mitomycin C and metabolites in cell lines with different resistance patterns.
Dirix LY; Gheuens EE; van der Heyden S; van Oosterom AT; De Bruijn EA
Anticancer Drugs; 1994 Jun; 5(3):343-54. PubMed ID: 7919460
[TBL] [Abstract][Full Text] [Related]
13. Modulation of sensitivity to mitomycin C and a dithiol analogue by tempol in non-small-cell lung cancer cell lines under hypoxia.
Bando T; Kasahara K; Shibata K; Numata Y; Heki U; Shirasaki H; Iwasa K; Fujimura M; Matsuda T
J Cancer Res Clin Oncol; 1996; 122(1):21-6. PubMed ID: 8543588
[TBL] [Abstract][Full Text] [Related]
14. Interactions of mitomycin C with mammalian DNA detected by alkaline elution.
Dorr RT; Bowden GT; Alberts DS; Liddil JD
Cancer Res; 1985 Aug; 45(8):3510-6. PubMed ID: 3926301
[TBL] [Abstract][Full Text] [Related]
15. Mode of action of C-1027, a new macromolecular antitumor antibiotic with highly potent cytotoxicity, on human hepatoma BEL-7402 cells.
Xu YJ; Li DD; Zhen YS
Cancer Chemother Pharmacol; 1990; 27(1):41-6. PubMed ID: 2173979
[TBL] [Abstract][Full Text] [Related]
16. Comparison of uptake of mitomycin C and KW-2149 by murine P388 leukemia cells sensitive or resistant to mitomycin C.
Kobayashi E; Okabe M; Kono M; Arai H; Kasai M; Gomi K; Lee JH; Inaba M; Tsuruo T
Cancer Chemother Pharmacol; 1993; 32(1):20-4. PubMed ID: 8096440
[TBL] [Abstract][Full Text] [Related]
17. Natural flavonoids and lignans are potent cytostatic agents against human leukemic HL-60 cells.
Hirano T; Gotoh M; Oka K
Life Sci; 1994; 55(13):1061-9. PubMed ID: 8084211
[TBL] [Abstract][Full Text] [Related]
18. Cell growth inhibition and DNA incorporation of mitomycin C in cell culture.
Takahashi N; Murayama T; Oda M; Miyakoshi M
Ophthalmic Res; 1998; 30(2):120-5. PubMed ID: 9523291
[TBL] [Abstract][Full Text] [Related]
19. Damage to DNA strand and the effects of anticancer drugs.
Kanamaru R; Ishioka C; Konishi Y; Ishikawa A; Shibata H; Wakui A
Sci Rep Res Inst Tohoku Univ Med; 1989 Dec; 36(1-4):29-36. PubMed ID: 2640065
[TBL] [Abstract][Full Text] [Related]
20. KW-2149 (7-N-[2-[gamma-L-glutamylamino]ethyldithioethyl] mitomycin C): DNA interactions and drug uptake following serum activation.
McAdam SR; Knox RJ; Hartley JA; Masters JR
Biochem Pharmacol; 1998 Jun; 55(11):1777-83. PubMed ID: 9714295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
